McKesson Other Non-Current Liabilities 2010-2024 | MCK
McKesson other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- McKesson other non-current liabilities for the quarter ending June 30, 2024 were $2.525B, a 21.75% increase year-over-year.
- McKesson other non-current liabilities for 2024 were $2.61B, a 43.96% increase from 2023.
- McKesson other non-current liabilities for 2023 were $1.813B, a 17.73% increase from 2022.
- McKesson other non-current liabilities for 2022 were $1.54B, a 10.2% decline from 2021.
McKesson Annual Other Non-Current Liabilities
(Millions of US $) |
| 2024 |
$2,610 |
| 2023 |
$1,813 |
| 2022 |
$1,540 |
| 2021 |
$1,715 |
| 2020 |
$1,662 |
| 2019 |
$2,103 |
| 2018 |
$2,625 |
| 2017 |
$1,774 |
| 2016 |
$1,809 |
| 2015 |
$1,863 |
| 2014 |
$2,897 |
| 2013 |
$1,838 |
| 2012 |
$1,504 |
| 2011 |
$1,353 |
| 2010 |
$1,352 |
| 2009 |
$1,178 |
McKesson Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-06-30 |
$2,525 |
| 2024-03-31 |
$2,610 |
| 2023-12-31 |
$2,381 |
| 2023-09-30 |
$2,197 |
| 2023-06-30 |
$2,074 |
| 2023-03-31 |
$1,813 |
| 2022-12-31 |
$1,804 |
| 2022-09-30 |
$1,541 |
| 2022-06-30 |
$1,553 |
| 2022-03-31 |
$1,540 |
| 2021-12-31 |
$1,612 |
| 2021-09-30 |
$1,564 |
| 2021-06-30 |
$1,748 |
| 2021-03-31 |
$1,715 |
| 2020-12-31 |
$1,846 |
| 2020-09-30 |
$1,669 |
| 2020-06-30 |
$1,703 |
| 2020-03-31 |
$1,662 |
| 2019-12-31 |
$1,836 |
| 2019-09-30 |
$1,950 |
| 2019-06-30 |
$2,016 |
| 2019-03-31 |
$2,103 |
| 2018-12-31 |
$2,195 |
| 2018-09-30 |
$2,197 |
| 2018-06-30 |
$2,448 |
| 2018-03-31 |
$2,625 |
| 2017-12-31 |
$2,807 |
| 2017-09-30 |
$2,082 |
| 2017-06-30 |
$1,938 |
| 2017-03-31 |
$1,774 |
| 2016-12-31 |
$1,684 |
| 2016-09-30 |
$1,727 |
| 2016-06-30 |
$1,768 |
| 2016-03-31 |
$1,809 |
| 2015-12-31 |
$2,555 |
| 2015-09-30 |
$2,625 |
| 2015-06-30 |
$2,741 |
| 2015-03-31 |
$1,863 |
| 2014-12-31 |
$2,734 |
| 2014-09-30 |
$2,749 |
| 2014-06-30 |
$2,855 |
| 2014-03-31 |
$2,897 |
| 2013-12-31 |
$2,027 |
| 2013-09-30 |
$2,058 |
| 2013-06-30 |
$2,080 |
| 2013-03-31 |
$1,838 |
| 2012-12-31 |
$1,603 |
| 2012-09-30 |
$1,430 |
| 2012-06-30 |
$1,376 |
| 2012-03-31 |
$1,504 |
| 2011-12-31 |
$1,408 |
| 2011-09-30 |
$1,368 |
| 2011-06-30 |
$1,383 |
| 2011-03-31 |
$1,353 |
| 2010-12-31 |
$1,326 |
| 2010-09-30 |
$1,313 |
| 2010-06-30 |
$1,352 |
| 2010-03-31 |
$1,352 |
| 2009-12-31 |
$1,204 |
| 2009-09-30 |
$1,191 |
| 2009-06-30 |
$1,213 |
| 2009-03-31 |
$1,178 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$78.143B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
